A novel translational approach for human malignant pleural mesothelioma: Heparanase-assisted dual virotherapy

Y. Watanabe, T. Kojima, Shunsuke Kagawa, F. Uno, Y. Hashimoto, S. Kyo, H. Mizuguchi, N. Tanaka, H. Kawamura, D. Ichimaru, Y. Urata, Toshiyoshi Fujiwara

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that is related to asbestos exposure. MPM is characterized by rapid and diffuse local growth in the thoracic cavity, and it has a poor prognosis because it is often refractory to conventional therapy. Although MPM is an extraordinarily challenging disease to treat, locoregional virotherapy may be useful against this aggressive disease because of the accessibility by intrapleural virus delivery. In this study, we show that telomerase-specific, replication-selective adenovirus OBP-301 can efficiently infect and kill human mesothelioma cells by viral replication. Intrathoracic administration of virus significantly reduced the number and size of human mesothelioma tumors intrathoracically implanted into nu/nu mice. A high-definition, fluorescence optical imaging system with an ultra-thin, flexible fibered microprobe clearly detected intracellular replication of green fluorescent protein-expressing oncolytic virus in intrathoracically established mesothelioma tumors. As the extracellular matrix (ECM) may contribute to the physiological resistance of a solid tumor by preventing the penetration of therapeutic agents (including oncolytic viruses), we also examined whether the co-expression of heparanase, an endoglucuronidase capable of specifically degrading heparan sulfate, that influences the physiological barrier to macromolecule penetration, can modify the permeability of the ECM, resulting in profound therapeutic efficacy. Co-injection of OBP-301 and a replication-defective adenovirus (Ad-S/hep)-expressing heparanase resulted in more profound antitumor effects without apparent toxicity in an orthotopic pleural dissemination model. Our results suggest that intrathoracic dual virotherapy with telomerase-specific oncolytic adenovirus in combination with heparanase-expressing adenovirus may be efficacious in the prevention and treatment of pleural dissemination of human malignant mesothelioma.

Original languageEnglish
Pages (from-to)1145-1154
Number of pages10
JournalOncogene
Volume29
Issue number8
DOIs
Publication statusPublished - Feb 2010

Fingerprint

Adenoviridae
Mesothelioma
Oncolytic Viruses
Telomerase
Optical Imaging
Extracellular Matrix
Neoplasms
Viruses
Thoracic Cavity
Optical Devices
Heparitin Sulfate
Asbestos
Glucuronidase
Therapeutics
Green Fluorescent Proteins
Permeability
Injections
heparanase
Malignant Mesothelioma
Growth

Keywords

  • Adenovirus
  • Dual virotherapy
  • Heparanase
  • Mesothelioma
  • Telomerase

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

A novel translational approach for human malignant pleural mesothelioma : Heparanase-assisted dual virotherapy. / Watanabe, Y.; Kojima, T.; Kagawa, Shunsuke; Uno, F.; Hashimoto, Y.; Kyo, S.; Mizuguchi, H.; Tanaka, N.; Kawamura, H.; Ichimaru, D.; Urata, Y.; Fujiwara, Toshiyoshi.

In: Oncogene, Vol. 29, No. 8, 02.2010, p. 1145-1154.

Research output: Contribution to journalArticle

Watanabe, Y, Kojima, T, Kagawa, S, Uno, F, Hashimoto, Y, Kyo, S, Mizuguchi, H, Tanaka, N, Kawamura, H, Ichimaru, D, Urata, Y & Fujiwara, T 2010, 'A novel translational approach for human malignant pleural mesothelioma: Heparanase-assisted dual virotherapy', Oncogene, vol. 29, no. 8, pp. 1145-1154. https://doi.org/10.1038/onc.2009.415
Watanabe, Y. ; Kojima, T. ; Kagawa, Shunsuke ; Uno, F. ; Hashimoto, Y. ; Kyo, S. ; Mizuguchi, H. ; Tanaka, N. ; Kawamura, H. ; Ichimaru, D. ; Urata, Y. ; Fujiwara, Toshiyoshi. / A novel translational approach for human malignant pleural mesothelioma : Heparanase-assisted dual virotherapy. In: Oncogene. 2010 ; Vol. 29, No. 8. pp. 1145-1154.
@article{1e2a8ad1c4bc4c8190b9d1bd2927ce58,
title = "A novel translational approach for human malignant pleural mesothelioma: Heparanase-assisted dual virotherapy",
abstract = "Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that is related to asbestos exposure. MPM is characterized by rapid and diffuse local growth in the thoracic cavity, and it has a poor prognosis because it is often refractory to conventional therapy. Although MPM is an extraordinarily challenging disease to treat, locoregional virotherapy may be useful against this aggressive disease because of the accessibility by intrapleural virus delivery. In this study, we show that telomerase-specific, replication-selective adenovirus OBP-301 can efficiently infect and kill human mesothelioma cells by viral replication. Intrathoracic administration of virus significantly reduced the number and size of human mesothelioma tumors intrathoracically implanted into nu/nu mice. A high-definition, fluorescence optical imaging system with an ultra-thin, flexible fibered microprobe clearly detected intracellular replication of green fluorescent protein-expressing oncolytic virus in intrathoracically established mesothelioma tumors. As the extracellular matrix (ECM) may contribute to the physiological resistance of a solid tumor by preventing the penetration of therapeutic agents (including oncolytic viruses), we also examined whether the co-expression of heparanase, an endoglucuronidase capable of specifically degrading heparan sulfate, that influences the physiological barrier to macromolecule penetration, can modify the permeability of the ECM, resulting in profound therapeutic efficacy. Co-injection of OBP-301 and a replication-defective adenovirus (Ad-S/hep)-expressing heparanase resulted in more profound antitumor effects without apparent toxicity in an orthotopic pleural dissemination model. Our results suggest that intrathoracic dual virotherapy with telomerase-specific oncolytic adenovirus in combination with heparanase-expressing adenovirus may be efficacious in the prevention and treatment of pleural dissemination of human malignant mesothelioma.",
keywords = "Adenovirus, Dual virotherapy, Heparanase, Mesothelioma, Telomerase",
author = "Y. Watanabe and T. Kojima and Shunsuke Kagawa and F. Uno and Y. Hashimoto and S. Kyo and H. Mizuguchi and N. Tanaka and H. Kawamura and D. Ichimaru and Y. Urata and Toshiyoshi Fujiwara",
year = "2010",
month = "2",
doi = "10.1038/onc.2009.415",
language = "English",
volume = "29",
pages = "1145--1154",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - A novel translational approach for human malignant pleural mesothelioma

T2 - Heparanase-assisted dual virotherapy

AU - Watanabe, Y.

AU - Kojima, T.

AU - Kagawa, Shunsuke

AU - Uno, F.

AU - Hashimoto, Y.

AU - Kyo, S.

AU - Mizuguchi, H.

AU - Tanaka, N.

AU - Kawamura, H.

AU - Ichimaru, D.

AU - Urata, Y.

AU - Fujiwara, Toshiyoshi

PY - 2010/2

Y1 - 2010/2

N2 - Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that is related to asbestos exposure. MPM is characterized by rapid and diffuse local growth in the thoracic cavity, and it has a poor prognosis because it is often refractory to conventional therapy. Although MPM is an extraordinarily challenging disease to treat, locoregional virotherapy may be useful against this aggressive disease because of the accessibility by intrapleural virus delivery. In this study, we show that telomerase-specific, replication-selective adenovirus OBP-301 can efficiently infect and kill human mesothelioma cells by viral replication. Intrathoracic administration of virus significantly reduced the number and size of human mesothelioma tumors intrathoracically implanted into nu/nu mice. A high-definition, fluorescence optical imaging system with an ultra-thin, flexible fibered microprobe clearly detected intracellular replication of green fluorescent protein-expressing oncolytic virus in intrathoracically established mesothelioma tumors. As the extracellular matrix (ECM) may contribute to the physiological resistance of a solid tumor by preventing the penetration of therapeutic agents (including oncolytic viruses), we also examined whether the co-expression of heparanase, an endoglucuronidase capable of specifically degrading heparan sulfate, that influences the physiological barrier to macromolecule penetration, can modify the permeability of the ECM, resulting in profound therapeutic efficacy. Co-injection of OBP-301 and a replication-defective adenovirus (Ad-S/hep)-expressing heparanase resulted in more profound antitumor effects without apparent toxicity in an orthotopic pleural dissemination model. Our results suggest that intrathoracic dual virotherapy with telomerase-specific oncolytic adenovirus in combination with heparanase-expressing adenovirus may be efficacious in the prevention and treatment of pleural dissemination of human malignant mesothelioma.

AB - Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that is related to asbestos exposure. MPM is characterized by rapid and diffuse local growth in the thoracic cavity, and it has a poor prognosis because it is often refractory to conventional therapy. Although MPM is an extraordinarily challenging disease to treat, locoregional virotherapy may be useful against this aggressive disease because of the accessibility by intrapleural virus delivery. In this study, we show that telomerase-specific, replication-selective adenovirus OBP-301 can efficiently infect and kill human mesothelioma cells by viral replication. Intrathoracic administration of virus significantly reduced the number and size of human mesothelioma tumors intrathoracically implanted into nu/nu mice. A high-definition, fluorescence optical imaging system with an ultra-thin, flexible fibered microprobe clearly detected intracellular replication of green fluorescent protein-expressing oncolytic virus in intrathoracically established mesothelioma tumors. As the extracellular matrix (ECM) may contribute to the physiological resistance of a solid tumor by preventing the penetration of therapeutic agents (including oncolytic viruses), we also examined whether the co-expression of heparanase, an endoglucuronidase capable of specifically degrading heparan sulfate, that influences the physiological barrier to macromolecule penetration, can modify the permeability of the ECM, resulting in profound therapeutic efficacy. Co-injection of OBP-301 and a replication-defective adenovirus (Ad-S/hep)-expressing heparanase resulted in more profound antitumor effects without apparent toxicity in an orthotopic pleural dissemination model. Our results suggest that intrathoracic dual virotherapy with telomerase-specific oncolytic adenovirus in combination with heparanase-expressing adenovirus may be efficacious in the prevention and treatment of pleural dissemination of human malignant mesothelioma.

KW - Adenovirus

KW - Dual virotherapy

KW - Heparanase

KW - Mesothelioma

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=77649192334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649192334&partnerID=8YFLogxK

U2 - 10.1038/onc.2009.415

DO - 10.1038/onc.2009.415

M3 - Article

C2 - 19935710

AN - SCOPUS:77649192334

VL - 29

SP - 1145

EP - 1154

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 8

ER -